???global.info.a_carregar???
Catarina Correia Teixeira has completed her Chemistry degree in Faculty of Sciences of University of Porto in 2019 with a complementary training (minor) in Biology and also, an extra-curricular internship in REQUIMTE lab, where she studied the role of polyphenols in metabolomics. Her Master in Biochemistry in Health - Branch of Clinical and Metabolic Biochemistry was concluded in 2021 in Polytechnic Institute of Porto. During this time, she developed her dissertation entitled "The impact of obesity in renal fibrosis" which allowed her first-author paper publication: "Enhanced 3T3-L1 differentiation into adipocytes by pioglitazone pharmacological activation of peroxisome proliferator-activated receptor gamma". She was also a Researcher in Institute for Research and Innovation in Health (metabesity group) and in Laboratory of Medical and Industrial Biotechnology | PORTIC (Porto Research, Technology and Innovation Center) - Polytechnic Institute of Porto where she was involved in studies of cellular and molecular behavior, as well as molecular virology, using animal and cell models and in molecular diagnostics of diseases. As a result, she published some scientific papers and participated as author and co-author in 3 conferences. In the year 22/23, she attended at the PhD in Advanced Biotechnology in University of Vigo and currently she is a Neuroscience PhD student fellow in Institute for Research and Innovation in Health (i3s - Addiction Biology group) and Faculty of Medicine of University of Porto.
Identification

Personal identification

Full name
Catarina Correia Teixeira

Citation names

  • Teixeira, Catarina
  • Teixeira, C

Author identifiers

Ciência ID
F414-DA83-F977
ORCID iD
0000-0001-6934-7641

Knowledge fields

  • Medical and Health Sciences - Medical Biotechnology - Health-Related Biotechnology
  • Medical and Health Sciences - Medical Biotechnology - Technologies Involving the Manipulation of Cells, Tissues, Organs or the Whole Organism
  • Medical and Health Sciences - Basic Medicine - Neurosciences

Languages

Language Speaking Reading Writing Listening Peer-review
Portuguese (Mother tongue)
English Upper intermediate (B2) Upper intermediate (B2) Upper intermediate (B2) Upper intermediate (B2)
Education
Degree Classification
2023/06/06 - 2027/09
Ongoing
Neurociências (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
"Repurposing Felodipine as a modulator of the brain-heart-kidney axis" (THESIS/DISSERTATION)
2022/02 - 2023/06/09
Attended
Doctoral Programme in Advanced Biotechnology (Doctor of Philosophy)
Universidade de Vigo - Campus Lagoas Marcosende, Spain
2021/02/22 - 2021/05/07
Concluded
Clinical Microbiology of COVID-19: Molecular Diagnosis and Public Health (Graduate) (Pós-Graduação)
LaBMI/PORTIC- Porto Research Technology & Innovation Center of the Polytechnic Institute of Porto., Portugal
Approved
2021/02/15 - 2021/02/26
Concluded
Techniques of Harvesting Biological Products for the Laboratory Diagnosis of COVID-19 (Outros)
LaBMI/PORTIC- Porto Research Technology & Innovation Center of the Polytechnic Institute of Porto., Portugal
Approved
2019 - 2021
Concluded
Biochemistry in Health (Mestrado)
Major in Clinical and Metabolic Biochemistry
Instituto Politécnico do Porto Escola Superior de Saúde, Portugal
"The Impact of Obesity in Renal Fibrosis" (THESIS/DISSERTATION)
18
2016 - 2019
Concluded
Chemistry (Licenciatura)
Major in Complementary Formation in Biology
Universidade do Porto Faculdade de Ciências, Portugal
Affiliation

Science

Category
Host institution
Employer
2022/10/01 - 2026/10/01 Researcher (Research) Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2021 - 2022/09/30 Contracted Researcher (Research) Instituto Politécnico do Porto, Portugal
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal

Others

Category
Host institution
Employer
2020/09 - 2021 Volunteer Instituto Politécnico do Porto, Portugal
2019/02/01 - 2019/07/31 Extracurricular internship Universidade do Porto Faculdade de Ciências, Portugal
Projects

Grant

Designation Funders
2022/10/01 - Current Repurposing Felodipine as a modulator of the Brain-Heart-Kidney axis
2022.12641.BD
PhD Student Fellow
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Ongoing
2021 - 2021 IPP4COVID - Prevention and Sustainable Optimization of the Diagnosis of COVID-19 on a Large Scale
IPP4COVID/BI/02/2020
Research Fellow
Instituto Politécnico do Porto, Portugal
Ongoing

Contract

Designation Funders
2023/03/12 - 2024/09/11 Use of Aptarmers towards Theranostics and Precision Medicine in Prostate Carcinoma
2022.09032.PTDC
Fundação Ensino e Cultura Fernando Pessoa, Portugal

Instituto Politécnico do Porto, Portugal
Fundação para a Ciência e a Tecnologia
Ongoing

Other

Designation Funders
2020 - 2020/08 IPP4AVSS - Support for SARS-CoV-2 molecular diagnosis at ACES Tâmega II Vale do Sousa Sul
112_596698921
Volunteer
LaBMI/PORTIC- Porto Research Technology & Innovation Center of the Polytechnic Institute of Porto., Portugal
Concluded
2020 - 2020/08 IPP4AFA - Support for SARS-CoV-2 molecular diagnosis at ACES Entre Douro e Vouga II Feira / Arouca
104_596694627
Volunteer
LaBMI/PORTIC- Porto Research Technology & Innovation Center of the Polytechnic Institute of Porto., Portugal
Concluded
Outputs

Publications

Conference paper
  1. Gomes, Emílio*; Brandão, Isabel*; Teixeira, Catarina; Ramil-Gómez, Olalla; Carvalho, Eduarda; Fernandes, Rúben; Silva, Roberto; et al. "Evaluation of a new player in renal fibroblast activation". Paper presented in Encontro de Investigação Jovem da U.Porto (IJUP), Porto, 2023.
Conference poster
  1. Teixeira, Catarina; Falcão-Pires, Inês; Inês Alencastre; Teixeira, Fábio G. "Repurposing Felodipine as a modulator of the Brain-Heart-Kidney axis". 2023.
  2. Rocha, Ana Catarina; André P Sousa; Teixeira, Catarina; Almeida, Cátia; Baylina, Pilar; Soares, Raquel; Martins-Mendes, Daniela; Fernandes, Ruben. "Adiposidade promovida pela Pioglitazona potencia a agressividade de tumores do pâncreas em pacientes obesos". Paper presented in 19º Congresso Português de Diabetes, 2023.
  3. Alexandra Aveiro; Carla Guedes; Teixeira, Catarina; André Sousa; Cátia Almeida; Sónia Mendo; Pilar Baylina; Ruben Fernandes; Ana Cláudia Pereira. "The influence of secretome adipocytes on bacterial infections and immune response". Paper presented in 1st Conference of the Doctoral Program in Metabolism Clinical and Experimental, 2022.
  4. Aveiro, Alexandra; Soares-Guedes, Carla; André P Sousa; Teixeira, Catarina; Baylina Machado, Pilar; Pereira, Ana. "The influence of adipocytes¿ secretome and imune response on bacterial growth". Paper presented in 1st Conference of the Doctoral Program in Metabolism ¿ Clinical and experimental, 2022.
  5. João Monteiro; Teixeira, Catarina; Cláudia Pereira; Pilar Baylina; Rúben Fernandes; Patrick Joel Pais. "Método alternativo, mais rápido e economicamente acessível, de cultura de células mononucleares do sangue periférico (PBMCs)". Paper presented in I Congresso de Ciências, 2022.
  6. Oliveira, Marco; Soares, Sílvia; André P Sousa; Teixeira, Catarina; Correa-Duarte, Miguel; Carla F. Pereira; Baylina Machado, Pilar; Fernandes, Ruben. "Otimização da biossíntese de nanopartículas de ouro e o seu potencial terapêutico no cancro da próstata". Paper presented in 4º ENCONTRO NACIONAL JOVENS INVESTIGADORES EM ONCOLOGIA - Liga Portuguesa Contra o Cancro, 2022.
  7. "Caco-2: a model to test the infectivity of SARS-CoV-2.". Paper presented in Porto Cancer Meeting 2021, 2021.
  8. "Biopotential from antidiabetic drugs exploiting therapeutical approaches for prostate cancer.". Paper presented in Porto Cancer Meeting 2021, 2021.
  9. "Role of polymorphisms of ACE2 and Spike proteins in SARS-CoV-2 infection.". Paper presented in IJUP, 2021.
  10. "Morphopathological alterations in the kidney of obese and insulin-resistant rats.". Paper presented in 17º Congresso Português de Diabetes, (online), 2021.
  11. "Evaluation of the antitumor potential of antidiabetic drugs in prostate cancer.". Paper presented in 17º Congresso Português de Diabetes, 2021.
  12. "Effect of testosterone and estradiol on the diabetes/prostate cancer paradox.". Paper presented in 17º Congresso Português de Diabetes, 2021.
  13. Teixeira, Catarina; Baylina, Pilar; Fernandes, Ruben. "Alterações morfopatológicas no rim de rato com obesidade e insulino-resistência". Paper presented in 17º Portuguese Diabetes Congress, 2021.
Journal article
  1. Vilela, Cristiana; Araújo, Bruna; Soares-Guedes, Carla; Caridade-Silva, Rita; Martins-Macedo, J; Teixeira, Catarina; Gomes, Eduardo D.; et al. Corresponding author: Teixeira, Fábio G. "From the Gut to the Brain: Is microbiome a new paradigm in Parkinson’s Disease Treatment?". Cells (2024):
    Accepted
  2. Sousa, André; Coelho, Pedro; Leite, Fernanda; Teixeira, Catarina; Rocha, Ana Catarina; Santos, Inês; Baylina, Pilar; et al. "Impact of umbilical cord mesenchymal stromal/stem cell secretome and cord blood serum in prostate cancer progression". Human Cell (2023): http://dx.doi.org/10.1007/s13577-023-00880-z.
    10.1007/s13577-023-00880-z
  3. Catarina Teixeira; André P. Sousa; Inês Santos; Ana Catarina Rocha; Inês Alencastre; Ana Cláudia Pereira; Daniela Martins-Mendes; et al. "Enhanced 3T3-L1 Differentiation into Adipocytes by Pioglitazone Pharmacological Activation of Peroxisome Proliferator Activated Receptor-Gamma (PPAR-¿)". Biology (2022): https://doi.org/10.3390/biology11060806.
    10.3390/biology11060806
  4. "Cannabidiol and Terpene Formulation Reducing SARS-CoV-2 Infectivity Tackling a Therapeutic Strategy". Frontiers In Immunology (2022): https://doi.org/10.3389/fimmu.2022.841459.
    10.3389/fimmu.2022.841459
  5. André P. Sousa; Diogo M. Cunha; Carolina Franco; Catarina Teixeira; Frantz Gojon; Pilar Baylina; Ruben Fernandes. "Which Role Plays 2-Hydroxybutyric Acid on Insulin Resistance?". Metabolites 11 12 (2021): 835-835. https://doi.org/10.3390/metabo11120835.
    10.3390/metabo11120835
Thesis / Dissertation
  1. "The Impact of Obesity in Renal Fibrosis". Master, Instituto Politécnico do Porto Escola Superior de Saúde, 2021.